-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Prices 6.17M Share Offering at $81/sh
-
-
-
-
-
-
-
Baird 'Incrementally Positive' on Sarepta (SRPT) on Solid Biosciences Clinical Hold
-
-
-
-
-
-
-
Baird Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Raised to $202 at Baird on Gene Therapy Potential
-
-
-
-
-
-
-
Sarepta (SRPT) SRP-4053 Data Strengthen Case for Exon Expansion Approach - Baird; Reit. OP, $101 PT
-
-
-
-
-
-
-
Sarepta (SRPT) Exondys 51 Prescriptions 'Almost Doubled' Since November, Baird Survey Shows
-
-
-
-
-
-
-
Baird Says No Change to Sarepta (SRPT) Outlook Amid Anthem Slight
-
27,186 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

